Global Focus Financial News

Danish pharmaceutical company Ascendis Pharma A/S (ASND) announced that the United Kingdom\'s Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for YORVIPATH (palopegteriparatide; developed as TransCon PTH) in Great Britain as a parathyroid hormone (PTH) replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism The MHRA has also granted YORVIPATH...

The Canadian market, which fell after a slightly positive start and a subsequent rise to a new record high Monday morning, continues to languish in negative territory in cautious trade and looks headed for a weak close. Technology, real estate and financial shares are among the notable losers. Energy and materials stocks are finding some...

Giving up some of the gains in the previous two sessions, the Australian stock market is notably lower on Friday, following the broadly negative cues from global markets overnight. The benchmark S&P/ASX 200 is staying below the 7,900 level, with losses across most sectors led by gold miners and technology stocks. Iron ore miners are...

The UK housing market conditions strengthened in August as the recent decrease in mortgage interest rates spurred demand and sales activity, the latest survey from the Royal Institution of Chartered Surveyors showed on Thursday. The number of people looking to buy homes increased in August, with the balance rising to 15 from 4 in July....